Site icon Hot Paths

Chinese biotech dominance in R&D on the rise (MRK:NYSE)

Jan. 18, 2025 3:56 PM ETMerck & Co., Inc. (MRK) Stock, AZN StockGSK, NVS, RHHBY, NVO, LLY, NVSEF, RHHBF, ABBV, GCVRZ, SMMT, HNSPF, AKESFBy: Dulan Lokuwithana, SA News Editor
Directional signs of international flags on post

narvikk/E+ via Getty Images

Against a backdrop of rising U.S.-China geopolitical tensions, there are signs of growing dealmaking activity between Western pharmaceutical companies and Chinese biotechs, multiple research firms suggest.

Large pharma companies have in-licensed nearly a third of their external molecules from Chinese

Exit mobile version